Logo

B-cell lymphoma study identifies traits tied to greatest benefit from CD19 CAR T cell therapy

B-cell lymphoma study identifies traits tied to greatest benefit from CD19 CAR T cell therapy

In the largest study of its kind, researchers from The University of Texas MD Anderson Cancer Center identified three subgroups of patients with large B-cell lymphoma (LBCL) who have different levels of benefit from CD19 chimeric antigen receptor (CAR) T cell therapy.

šŸ‘‰ Full Story